|
Quotes & Info
|
| IMUC > SEC Filings for IMUC > Form 8-K on 4-Mar-2013 | All Recent SEC Filings |
4-Mar-2013
Other Events
On March 4, 2013, ImmunoCellular Therapeutics, Ltd. (the "Company") issued a press release announcing the issuance of a key patent for the Company's ICT-121 cancer vaccine. A copy of the press release is attached hereto as Exhibit 99.1
|
|